Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2025

MAPkinase

Hyper activation of RAS signaling as a cancer treatment strategy

Date

04 Mar 2025

Session

MAPkinase

Topics

Cancer Biology;  Cytotoxic Therapy;  Translational Research;  Targeted Therapy;  Molecular Oncology

Tumour Site

Soft Tissue Sarcomas;  Hepatobiliary Cancers;  Pancreatic Adenocarcinoma;  Colon and Rectal Cancer

Presenters

Matheus Henrique Dias

Authors

M.H. Dias

Author affiliations

  • Netherlands Cancer Institute, 1006 BE - Amsterdam/NL

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.